The recently discovered crAssphage is by far the most abundant and ubiquitous known 11 human gut bacteriophage. It appears to be highly specific to the human gastrointestinal tract; 12 however, the patterns of transmission and persistence of this bacteriophage are unknown. Here, 13
and provide a foundation for future studies of the role of this phage in the biology of the human 23 microbiome. 24
25

Main text 26
In addition to trillions of bacteria, the human gastrointestinal tract is densely populated 27 with bacteriophages. Bacteriophages can drive bacterial community composition and mediate 28 horizontal gene transfer 1 , and alterations in the human gut virome have been associated with 29 disease 2,3 . Yet, our knowledge of the contributions of specific bacteriophages to human biology 30 is limited, in part due to the paucity of viral sequences represented in reference databases. 31
High-throughput sequencing and advanced genomic tools have facilitated the in silico discovery 32 and characterization of previously unknown bacteriophages. The preeminent example of such a 33 discovery is crAssphage (cross Assembly phage), initially identified from human virome 34 sequencing data 4 . CrAssphage is a bacteriophage with an ~97 kilobase circular, double-35 stranded DNA genome. Interestingly, crAssphage sequences are found almost exclusively in 36 human fecal metagenomes, and can be highly abundant. Initial estimates indicate that 37 crAssphage is present in 73-77% of humans 4, 5 , challenging the notion that the gut virome is 38 highly individual-specific. Subsequently, it has been shown that a wide range of crAss-like 39 phages exists in nature 5, 6 . However, whether or how crAssphage influences host biology or is 40 involved in disease is unknown. To answer higher-order questions about the role of crAssphage 41 in human biology, it is necessary to establish basic principles of crAssphage acquisition, 42 persistence, and distribution. To this end, we analyzed crAssphage sequences from both 43 published and novel datasets, finding that crAssphage typically exhibits monoclonal dominance 44 in a given individual and can be transmitted vertically from mothers to infants as well as 45 horizontally in adults with compromised or simplified microbiomes. 46
47
To determine whether individuals have one or many crAssphage strains in the gut metagenome, 48
we identified sites with more than one variant present in the crAssphage genome (multi-allelic 49 sites) from stool metagenomic sequencing data from individuals from four cohorts (Table S1) 7-9 . 50
We aligned metagenomic sequencing reads to the crAssphage reference genome 4 and 51 identified single-nucleotide variants (SNVs) that are present at intermediate frequency (between 52 10% and 90% frequency). We limited our analysis to metagenomes with 30X coverage or 53 greater of the crAssphage genome. We find that 77 of 106 metagenomes (73%) have fewer 54 than 50 multiallelic sites (Figure 1 ), suggesting that most individuals are likely colonized by a 55 single crAssphage or near-identical crAssphages. 28 of 106 metagenomes (26%) have between 56 50 and 999 multiallelic sites, corresponding to polymorphism in roughly 0.05% to 0.999% of the 57 genome. One of 106 metagenomes (1%) have 1000 or more multiallelic sites, corresponding to 58 greater than 1% of the genome. These results suggest an exclusion principle which favors 59 colonization of a particular strain within the gut of an individual, though notably, a minority of 60 individuals may be simultaneously colonized by more than one crAssphage strain. The number 61 of multi-allelic sites stays relatively stable within individuals over time ( Figure S1 ). We observe 62 that SNVs are relatively evenly distributed throughout the genome ( Figure S2 (Figure 2 ). Of the 27 mother-infant pairs where crAssphage strains were 89 detected in at least one maternal sample, we find that 6 pairs (22%) share an identical or highly 90 related strain of crAssphage between the mother and infant, indicating that crAssphage can be 91 vertically transmitted from mother to infant. Ten of 142 infants (7%) harbor a strain of 92 crAssphage that is not detected in the mother's stool. This could be a result of sampling during 93 a low-crAssphage state in the mother; alternatively, these infants may have acquired 94
crAssphage from another individual in their household. 95
96
It has previously been reported that birth mode does not influence crAssphage relative 97 abundance in the gut virome of Irish infants 11 . In the two mother-infant cohorts analyzed here, 98
we only detect crAssphage in the gut microbiome of vaginally-born infants. Zero of 22 99
Cesarean-born infants have crAssphage in their stool samples at 5X coverage or greater; this is 100 not statistically significantly within this sample collection (Fisher's exact test; p=0.1332). 101
However, these samples were obtained from highly heterogeneous populations in diverse global 102 regions, and studies of larger cohorts are necessary to definitively determine the relationship 103 between birth mode and crAssphage colonization. Notably, crAssphage is not sufficiently 104 abundant to be detected in meconium or shortly after birth in our analysis and is only found in 105 infant stool sampled at least one month after birth. It is important to note, however, that these 106 datasets comprise total metagenomic shotgun sequencing as opposed to enriched viral 107 particles. It is possible that crAssphage particles are transmitted to the infant during vaginal birth 108 and persist in the infant gut, but that they are not detected until host Bacteroides strains achieve 109 higher relative abundance later in development 7,17,18 . Alternatively, it is possible that crAssphage 110 is not sufficiently abundant to be detected in total shotgun metagenomic data in some samples. 111
Finally, we observe that crAssphage strains are maintained in samples from multiple mothers 112 over time (for up to three months of sampling), consistent with previous findings that the human 113 gut virome is stable over time 19, 20 . 114 and fidaxomicin prior to transplantation. We observe that crAssphage is present at 1X coverage 149 or greater in samples from two donors, MGH06D and MGH03D. 12 recipients received stool 150 preparations from either of those two donors, and the donor crAssphage engrafts in nine of 151 those recipients (82%) (Figure 3a) . Each of those nine recipients received stool preparations 152 from the same donor (MGH03D), and the recipient strain is the same as the donor strain (Figure  153 3b). Zero recipients who received FMT from a crAssphage-negative donor acquired crAssphage 154 during the sampling period. In situations where crAssphage engrafts, it persists for days to 155 months corresponding to the duration of sampling (Figure 3a) . None of the recipients in this 156 study had crAssphage in their gut prior to FMT, suggesting that crAssphage is below the 157 detection limit, not as ubiquitous as has been described, or more likely, is cleared or 158 substantially diminished in abundance when individuals are treated with drugs such as 159 metronidazole, which have high activity against the likely crAssphage hosts, Bacteroides 160 species. The FMT data show that crAssphage can be acquired as an adult and can stably 161 engraft on a timescale of months. 162 The long-term stability of the dominant crAssphage strain that we observed in maternal and 173 FMT recipient subjects suggested that this stability is a characteristic of crAssphage. To further 174 evaluate that model, we next analyzed the persistence of crAssphage strains in a biospecimen 175 collection of longitudinal samples from HCT recipients (Sequencing read counts in table S3). 176
We compared phylogenetic relatedness of crAssphage strains in the gut microbiomes of these 177 patients over the course of sampling (0 to 4 months), and found that in most cases, the 178 dominant crAssphage strain identified in samples from a given individual is identical or near-179 identical over time, clustering together in a distinct clade (Figure 4a ). This suggests that the 180 majority of individuals who were studied have a dominant, stable crAssphage strain over the 181 course of many days to months. 182 We show that crAssphage can be vertically transmitted, and that it is usually present in the gut 214 as early as a few months after birth. We show that crAssphage persists through sampling on the 215 scale of months, and perhaps even longer, indicating that the host immune system tolerates this 216 phage and does not mount an immune response. This may provide an important clue toward 217 the evolutionary history of host and microbe, as the human immune system may have evolved 218 tolerance to this virus. Future work remains to determine precisely whether, and how, 219 crAssphage influences the gut ecosystem. To do so, it will be necessary to determine the 220 host(s) of these crAssphages through isolation and culture experiments. With this knowledge, it 221 will be possible to design and test hypotheses that will help to elucidate the role of crAssphage 222 in the biology of the human gut. Phylogenetic trees were constructed using the StrainSifter pipeline as previously described 16 . 264
Briefly, reads are aligned to the crAssphage reference genome using the Burrows-Wheeler 265 Aligner v0.7.10 28 and to include only high-confidence alignments with mapping quality of 60 266 using the SAMtools 29 view and filtered using BamTools 29,30 filter (v2.4.0) to include only reads 267 with 5 or fewer mismatches. Samples in which reads cover at least 50% of the genome at a 268 depth of 5X were included. Pileup files are created from BAM files using SAMtools mpileup, and 269
SNVs with at least 0.8 frequency are identified and concatenated into a fasta file, from which a 270 multiple sequence alignment is created using MUSCLE 29-31 and a phylogenetic tree is computed 271 using FastTree v2. 1.7 32 . Phylogenetic trees were midpoint rooted and visualized using the iTOL 272 web tool 33 . 273
274
FMT analysis 275
Phylogenetic trees of crAssphage-containing samples were generated using StrainSifter with 276 default parameters. Coverage of reads mapping to the crAssphage genome was determined 277 from StrainSifter output. Plots were generated using the R programming language (v3.4.0) using 278 the ggplot2 v2. 
Data availability 284
Publicly available datasets analyzed herein are show in Table S1 . Sequence data unique to this 285 manuscript will be deposited in the NCBI SRA at the time of publication. 286
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